Professional Experience
Professor Lassen has held numerous leadership positions in prestigious medical institutions. His experience demonstrates clinical excellence and a commitment to advancing oncology practice and patient care.
- Current Positions:
- Clinical Professor, Department of Clinical Medicine, University of Copenhagen
- Chief Consultant, Department of Oncology, Rigshospitalet, Copenhagen
- Previous Roles:
- Head of Department of Oncology, Rigshospitalet since February 2017
- Founder of the Phase 1 Unit at Rigshospitalet in 2005
- Initiator of the Copenhagen Prospective Personalized Oncology (CoPPO) program in 2013
- Leadership & Mentorship: Active mentor to junior oncologists and researchers, guiding clinical and academic development
Academic Contributions
Professor Lassen has made substantial contributions to academic medicine through research, teaching, and mentorship. His work has shaped clinical oncology practices and influenced new generations of physicians.
- Research Interests: Personalized cancer treatment, Phase 1 clinical trials, tumor genomics, targeted therapies
- Teaching Roles: Clinical Professor at the University of Copenhagen, involved in medical education, training courses, and mentoring young doctors
- Conference Engagement: Frequent speaker at international oncology conferences, contributing expertise on precision medicine
- Publications: Over 350 peer-reviewed articles on oncology research and clinical innovations
Areas of Expertise
Professor Lassen focuses on conditions and treatments that involve complex oncology cases and genetic profiling, offering tailored strategies for each patient.
- Conditions Treated:
- Brain tumors, including glioblastoma multiforme
- Solid tumors with specific genetic mutations
- Advanced-stage cancers requiring personalized therapy
- Clinical Strengths:
- Design and management of early-phase clinical trials
- Integration of genomic profiling in treatment planning
- Personalized treatment strategies based on molecular diagnostics
Publications and Research
Professor Lassen’s research has significantly impacted the understanding of cancer biology and treatment. His studies focus on practical applications for patients, particularly in personalized medicine.
- Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors – Highlighting how genetic profiling can guide therapy.
- A High-Throughput ImmunoHistoFluorescence (IHF) Method for Sub-Nuclear Protein Analysis in Tissue – Introducing a novel method for tumor characterization.
- Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care – Comparing targeted therapy to conventional treatment for better outcomes.
His work is indexed in major medical databases and demonstrates a commitment to translating research into clinical benefits, directly impacting patient care and treatment outcomes.
Patient Care Philosophy
Professor Lassen emphasizes a holistic and patient-centered approach. He believes in transparent communication, empathy, and integrating scientific innovation with individualized care plans.
- Communication & Empathy: Ensures patients understand treatment options and outcomes
- Personalized Care: Tailors treatments based on genetic testing and tumor profiling
- International Patient Services: Supports consultations and care planning for patients from abroad
- Cultural Sensitivity: Focuses on respectful and inclusive patient care
- Patient Education: Provides clear guidance on therapies, side effects, and recovery expectations
Professional Affiliations
Professor Lassen is affiliated with numerous prestigious medical and oncology organizations. His professional memberships highlight his global recognition and leadership in the field.
- European Society for Medical Oncology (ESMO): Board-certified member and active participant in oncology initiatives
- Danish Comprehensive Cancer Center (DCCC): Director of the Brain Tumor Center
- University of Copenhagen: Clinical Professor in Clinical Oncology, involved in curriculum development and research mentoring
- International Committees: Participates in global oncology boards and advisory panels
Through these affiliations, Professor Lassen contributes to shaping cancer treatment standards, establishing research protocols, and mentoring the next generation of oncology specialists worldwide.
FAQs
- Is Professor Ulrik Lassen, MD, PhD board-certified?
- Yes, he is board-certified in Medical Oncology by the European Society for Medical Oncology (ESMO).
- What types of surgeries does he perform?
- Professor Lassen focuses on medical oncology and personalized cancer treatments. Surgical interventions are coordinated through a multidisciplinary team of surgical oncologists.
- Does he treat international patients?
- Yes, Rigshospitalet offers services for international patients, including treatment planning and consultation for specialized cancer care.
- How long is the typical hospital stay?
- Hospital stay duration depends on the type of treatment, including clinical trials, chemotherapy, or other therapies. Duration is individualized based on patient needs.
- What languages does he speak?
- Professor Lassen is fluent in Danish and English, facilitating communication with both local and international patients.
- What is his approach to patient education?
- He emphasizes clear explanations of treatment options and outcomes, empowering patients to make informed decisions about their care.
- What makes him a leader in oncology?
- His leadership in personalized medicine programs, Phase 1 clinical trials, and academic research positions him as a global authority in oncology.
